TRIM65 is a potential oncogenic protein via ERK1/2 on Jurkat and Raji cells: A therapeutic target in human lymphoma malignancies. [electronic resource]
Producer: 20181217Description: 1503-1510 p. digitalISSN:- 1095-8355
- Apoptosis -- drug effects
- Carcinogenesis -- metabolism
- Cell Cycle Checkpoints -- drug effects
- Cell Proliferation -- drug effects
- Dihydropyridines -- pharmacology
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Gene Knockdown Techniques
- Gene Silencing
- Humans
- Jurkat Cells
- Lymphoma -- metabolism
- MAP Kinase Signaling System -- drug effects
- Molecular Targeted Therapy
- Protein Kinase Inhibitors -- pharmacology
- Tripartite Motif Proteins -- metabolism
- Ubiquitin-Protein Ligases -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.